These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 9039099)
21. A decrease in angiotensin receptor binding in rat brain nuclei by antisense oligonucleotides to the angiotensin AT1 receptor. Ambühl P; Gyurko R; Phillips MI Regul Pept; 1995 Oct; 59(2):171-82. PubMed ID: 8584752 [TBL] [Abstract][Full Text] [Related]
22. Long-term inhibition of the central alpha(2B)-adrenergic receptor gene via recombinant AAV-delivered antisense in hypertensive rats. Shenouda SM; Johns C; Kintsurashvili E; Gavras I; Gavras H Am J Hypertens; 2006 Nov; 19(11):1135-43. PubMed ID: 17070424 [TBL] [Abstract][Full Text] [Related]
23. Delivery of antisense DNA by vectors for prolonged effects in vitro and in vivo. Mohuczy D; Tang X; Phillips MI Methods Enzymol; 2000; 314():32-51. PubMed ID: 10565003 [No Abstract] [Full Text] [Related]
24. Long-term modifications of blood pressure in normotensive and spontaneously hypertensive rats by gene delivery of rAAV-mediated cytochrome P450 arachidonic acid hydroxylase. Zhang F; Chen CL; Qian JQ; Yan JT; Cianflone K; Xiao X; Wang DW Cell Res; 2005 Sep; 15(9):717-24. PubMed ID: 16212878 [TBL] [Abstract][Full Text] [Related]
26. Reversal of hypertension by angiotensin II type 1 receptor antisense gene therapy in the adult SHR. Katovich MJ; Gelband CH; Reaves P; Wang HW; Raizada MK Am J Physiol; 1999 Sep; 277(3):H1260-4. PubMed ID: 10484448 [TBL] [Abstract][Full Text] [Related]
27. Gene therapy for hypertension: the preclinical data. Phillips MI Methods Enzymol; 2002; 346():3-13. PubMed ID: 11883075 [TBL] [Abstract][Full Text] [Related]
28. Vigilant vector: heart-specific promoter in an adeno-associated virus vector for cardioprotection. Phillips MI; Tang Y; Schmidt-Ott K; Qian K; Kagiyama S Hypertension; 2002 Feb; 39(2 Pt 2):651-5. PubMed ID: 11882625 [TBL] [Abstract][Full Text] [Related]
29. Antisense inhibition of hypertension in the spontaneously hypertensive rat. Wielbo D; Sernia C; Gyurko R; Phillips MI Hypertension; 1995 Mar; 25(3):314-9. PubMed ID: 7875755 [TBL] [Abstract][Full Text] [Related]
30. Differential effects of angiotensin II type-1 receptor antisense oligonucleotides on renal function in spontaneously hypertensive rats. Yoneda M; Sanada H; Yatabe J; Midorikawa S; Hashimoto S; Sasaki M; Katoh T; Watanabe T; Andrews PM; Jose PA; Felder RA Hypertension; 2005 Jul; 46(1):58-65. PubMed ID: 15956107 [TBL] [Abstract][Full Text] [Related]
31. Antisense oligonucleotides targeting angiotensinogen: insights from animal studies. Wu CH; Wang Y; Ma M; Mullick AE; Crooke RM; Graham MJ; Daugherty A; Lu HS Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30530571 [TBL] [Abstract][Full Text] [Related]
32. Is gene therapy for hypertension possible? Phillips MI Hypertension; 1999 Jan; 33(1):8-13. PubMed ID: 9931074 [No Abstract] [Full Text] [Related]
33. Antisense inhibition of beta(1)-adrenergic receptor mRNA in a single dose produces a profound and prolonged reduction in high blood pressure in spontaneously hypertensive rats. Zhang YC; Bui JD; Shen L; Phillips MI Circulation; 2000 Feb; 101(6):682-8. PubMed ID: 10673262 [TBL] [Abstract][Full Text] [Related]
35. Antisense inhibition of brain renin-angiotensin system decreased blood pressure in chronic 2-kidney, 1 clip hypertensive rats. Kagiyama S; Varela A; Phillips MI; Galli SM Hypertension; 2001 Feb; 37(2 Pt 2):371-5. PubMed ID: 11230302 [TBL] [Abstract][Full Text] [Related]
36. Delivery of angiotensin II type 1 receptor antisense inhibits angiotensin action in neurons from hypertensive rat brain. Lu D; Raizada MK Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2914-8. PubMed ID: 7708748 [TBL] [Abstract][Full Text] [Related]
37. Intracisternal administration of Angiotensin II AT1 receptor antisense oligodeoxynucleotides protects against cerebral ischemia in spontaneously hypertensive rats. Yamakawa H; Phillips MI; Saavedra JM Regul Pept; 2003 Mar; 111(1-3):117-22. PubMed ID: 12609758 [TBL] [Abstract][Full Text] [Related]
38. Antisense inhibition of angiotensinogen in hepatoma cell culture is enhanced by cationic liposome delivery. Wielbo D; Shi N; Sernia C Biochem Biophys Res Commun; 1997 Mar; 232(3):794-9. PubMed ID: 9126356 [TBL] [Abstract][Full Text] [Related]
39. Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries. Wang T; Li H; Zhao C; Chen C; Li J; Chao J; Chao L; Xiao X; Wang DW Gene Ther; 2004 Sep; 11(17):1342-50. PubMed ID: 15175642 [TBL] [Abstract][Full Text] [Related]
40. The future of hypertension therapy: sense, antisense, or nonsense? Pachori AS; Huentelman MJ; Francis SC; Gelband CH; Katovich MJ; Raizada MK Hypertension; 2001 Feb; 37(2 Pt 2):357-64. PubMed ID: 11230300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]